Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Renard et al., 2015
JCI Insight 5 , 134359 (2020)
Table 4: Percent (%) of Patients with Type 2 Diabetes Experiencing at Least One Episode of Severe Hypoglycemia or Hypoglycemia on TRESIBA in Open-Label Adult Clinical Trials *OAD: oral antidiabetic agent, Hypoglycemia: a severe hypoglycemia episode or an episode where a laboratory or a self-measured glucose calibrated to plasma was less than 56 mg/dL or where a whole blood glucose was less than 50 mg/dL (i.e., with or without the presence of hypoglycemic symptoms)
Need for Further Studies While these findings are promising, there is a pressing need for further research to fully understand the potential benefits and risks of GLP-1 agonists for women with endometriosis
US$ 21.61
US$ 23.09
US$ 28.15
US$ 28.31
US$ 26.14
US$ 25.12
